Antigen presentation in humoral immunity and graft rejection 1
An immune response is initiated by the presence of antigen(s) which may occur in many forms in the host and include viral encoded determinants on the surface of cells infected by virus, toxins produced by bacteria, or foreign proteins or carbohydrates on the cell membranes of parasites, to name but a few. All of these foreign' molecules have to be presented to the host immune system in the context of self major histocompatability system (MHS) molecules, except in the case of T independent antigens. Helper T cells require to see antigen in association with class II MHS molecules (HLA DIDR in man, H-21 in mouse) whereas cytotoxic and suppressor T cells require to see antigen in the context of class I MHS molecules (HLA A, B C in man and H-2 KID in the mouse). It is evident that this requirement necessitates the processing of antigenic material on entry into the body. Degradation of antigenic material is performed by various phagocytic cells, amongst them those of the macrophage lineage. Macrophages, when they have high densities of class II molecules on their cell surface, are capable of presenting antigen to the immune system, particularly to helper T cells. Recently another type of antigen-presenting cell has also been defined. These are the dendritic cells of which at least two different classes have been identifiedthe follicular dendritic cell and the Langerhans' or interdigitating cell type.
This report describes recent experimental studies which have been made on the role of antigen-presenting cells in humoral immunity and graft rejection.
Professor J Humphrey (Royal Postgraduate Medical School) began by discussing the role of the follicular dendritic cell in the germinal centres of spleen and lymph node. These follicular dendritic cells are the focus of attention for proliferating B lymphocytes during the formation of germinal centres. Like all dendritic cells their morphology seems to be exquisitely adapted for their role. They carry many cytoplasmic processes which interdigitate amongst the surrounding lymphocytes. Studies with isotope-labelled antigens have shown that these cells are the main site of antigen localization in the follicle and this combined with their physical attraction for the B lymphocyte led many workers to postulate that 1 Report of meeting of the Section of' Clinical Immunology & Allergy, 19 April 1982 0141-0768/83/040316-05/$01.00/0 they played a pivotal role in the generation of primary B-cell memory.
Substantial evidence for this role has been provided by experiments originally carried out by Klaus & Humphrey (1977) and Klaus et al. (1980) to establish what function complement played in the development of primary B-cell memory. These experiments were carried out in . 'B' mice; these are animals which have been thymectomized, lethally irradiated and reconstituted with T-cell depleted fetal liver cells. Such mice are capable of generating B memory cells but can only make antibody responses if they are supplied with an adequate source of T-cell help. The ability to generate a population of B memory cells can be demonstrated in a classical adoptive transfer system. Primed B cells from 'B' mice plus primed T cells from a different mouse together with the appropriate antigen can be transferred to an irradiated recipient. Six days later the spleen can be removed and the number of antibodyproducing cells determined in a plaque assay. It is also possible to deplete these 'B' mice of detectable serum levels of the complement component C3 for up to nine days by treating them with cobra venom factor. An experiment was carried out to see whether these mice could develop primary B memory cells. They were primed to an appropriate antigen, treated with cobra venom factor and after 19 days the B-cell population of the spleen transferred as described previously with a primed T-cell pool plus antigen. No plaque-forming cells were obtained six days later. Further investigation demonstrated that these mice did not localize antigen on their follicular dendritic cells. This implied that C3 played a role in primary B-cell memory development, the most obvious being one in which immune complexes are 'fixed' to the membranes of the follicular dendritic cells by a mechanism requiring C3 activation. Subsequent experiments with bacterial levan, an antigen which spontaneously activates C3, showed that C3 was the only requirement for antigen to be localized on the follicular dendritic cells, as this occurred with this compound even in the absence of antibody.
These facts led to the expectation that preformed antigen-antibody complexes injected into mice would be more efficient at inducing primary B-cell memory than antigen alone. Experiments were carried out with antigen and antibody at different ratios within the complex and it was found that optimal priming occurred surrounding lymphocytes such that formation of germinal centres and the development and maintainence of primary B-cell memory occurs in the spleen and lymph nodes of primed animals.
As previously mentioned, self MHS molecules are intimately involved in the normal process of antigen presentation. However, the molecular interactions which occur during recognition of foreign HLA molecules are not yet fully understood. Foreign HLA molecules when presented to the immune system as an antigen provide the immunologist with a difficult academic question. Are the allogeneic molecules recognized by the host immune system as completely foreign molecules in the absence of self HLA-DR (particularly in the context of generation of T-cell help) or are they processed like any other antigen and recognized as modified self? In addition, it is not yet clear whether foreign HLA molecules need to be presented to the immune system by antigen-presenting cells. Professor Richard Batchelor (Royal Postgraduate Medical School) discussed this problem in the context of the many experiments which he and his colleagues have carried out in the rat, looking at the very potent immunogen, the allogeneic kidney (Lechler & Batchelor 1982) . Antigens of the MHS have long been recognized as being responsible for the strong immune response seen when organ allografts are transplanted into an allogeneic host. The supression of this response requires extremely aggressive immunotherapy. And yet MHS antigen does not always elicit a strong immune rejection. For example, murine red cells are extremely poor immunogens, despite the fact that they carry class I· MHS molecules. Rat platelets and intact but irradiated lympho-when Ag and Ab were at equivalence point. When monoclonal antibodies were injected as part of the Ag-Ab complex, only those capable of fixing complement were able to generate primary B-cell memory. It was also established that the Fe portion of the antibody, which interacts with the first complement component, was required for optimal priming to occur. A major surprise at this point was the fact that IgM antibodies were in fact not so potent. It was assumed at the time that this indicated that all mice are not very good at fixing complement with IgM antibodies, but it has now been demonstrated that this is exceptional and confined to certain strains of mice including those originally used in these studies. Studies with antibody from a myeloma expressing anti-DNP antibody were also carried out and it was found that B-cell memory was generated not only against DNP but against the idiotype of the antibody in this complex.
The absolute role of the follicular dendritic cell has still not been fully elucidated. What is clear is that once antigen-antibody complexes have been fixed on their cell surface, they become the focus of development for the germinal centre. Isolation of these cells for in vitro study is extremely difficult. Professor Humphrey and his colleague Deirdre Grennan (1982) have developed a method by which they can be isolated in sufficient numbers to allow characterization of their cell surface molecules to be .carried out. The enzyme collagenase is injected into a rat or mouse; the spleen is then removed and treated in vitro with neutral proteases. Gentle spinning and enrichment procedures result in the isolation of small numbers of these cells. Unfortunately they seem to rely on the integrity of the follicular architecture to maintain their characteristic morphology. Consequently in vitro they tend to withdraw their cytoplasmic processes and to clump together, resulting in the isolation of large synkaryon-type cells. However, sufficient numbers of single cells have been isolated to make it possible to obtain preparation of these cells and subsequently to stain them for their cell surface markers. Table I summarizes the information obtained.
What remains to be established about these cells? It is not yet known whether they are of bone marrow origin. To answer this question it will be necessary to construct chimaeric animals and then isolate and determine the phenotype of the follicular dendritic cells in their spleens. Also it is not known how long these cells survive in the body; certainly, experiments in animals suggest that they can survive for. periods as long as six months. Finally, it remains to be established just what sort. of molecular interactions occur between the other antigen-presenting cells and the 
weak +ve, probably at the surface + cytes are also weak immunogens; similarly, disrupted lymphocyte membranes are also very poor initiators of an immune response.
It has been established that passive enhancement of rats (strain A) with antibodies against the MHS molecules of an allogeneic kidney strain (A x B)F.. results in the acceptance .of the (A x O)F, kidney. It has subsequently been shown that this (A x O)FI kidney can be retransplanted to a secondary recipient (strain A) which has not received immunological enhancement treatment without further rejection. In contrast, primary recipients (strain A) which do not receive immunological enhancement reject allogeneic kidney grafts (A x O)FI in 10-12 days. Why is there such a difference in the immunogenicity of these kidney grafts? One of the most plausible explanations for such a difference would be the absence of (A x O)FI passenger cells, including antigen-presenting cells, in the long-surviving kidney graft. A series of experiments were therefore carried out to establish whether the immunogenicity of the long-surviving, immunologically-enhanced graft could be restored by the presence of (A x O)FI antigen-presenting cells. Rats of strain A were passively enhanced with antibodies against (A x O)FI cells, and then given an (A x O)FI graft. One month or more later the animals were rendered chimaeric by giving them a dose of irradiation and reconstituting with (A x O)FI bone marrow cells. Under these circumstances the primary recipients did not reject their grafts. The kidneys were then transferred to another recipient and it was found that graft rejection occurred in 10-12 days.
Which allogeneic bone marrow derived cell was responsible for this graft rejection? Another series of experiments was then carried out, in which long-term surviving kidney grafts were transferred to secondary recipients and simultaneously the animals were injected with different cell populations from (A x O)FI rats. It was found that neither the B-nor the T-cell fraction affected the immunogenicity of the graft. In contrast, .adherent cells (macrophages) were sometimes found to cause graft rejection to occur if given at high doses. In comparison, very low numbers of dendritic cells were found to have an extremely potent effect upon graft rejection, as few as 5 x 10 4 allogeneic dendritic cells giving rise to acute graft rejection in all of the animals tested. Injection of syngeneic dendritic cells did not result in graft destruction although all of the animals went through rejection episodes.
The results which demonstrated that the B cells did not elicit graft rejection are important. 0 cells carry high densities of class II molecules on their cell surface, the same as found on the'antigenpresenting cells. However. the results indicate that the presence of allogeneic class II molecules alone is not sufficient to induce an immune response. The allogeneic dendritic cell seems able to present the MHS antigens directly to the host immune system, so what is the difference between the dendritic cell and the B cell? Presumably the dendritic cell is capable of releasing a factor (interleukin I) which is necessary for the activation of TH cells, in addition to antigen recognition.
Professor Batchelor and his colleagues then postulated that antigen presentation can occur via two routes. The first involves direct presentation by allogeneic dendritic cells carrying class II molecules, directly to the host T cells. The second occurs by a route which requires antigen processing by the host dendritic cells.
They proposed that MHS incompatible, longsurviving, passenger cell depleted kidney grafts immunize by route II and therefore minimal suppressionshould besufficienttomaintaingraftsin good function. This was tested by comparing the dose of cylcophosphamide needed to suppress the rejection of an immunologically-enhanced graft compared to that of a normal graft in a fully allogeneic system. The effect of different doses was established when A grafts were transferred to B recipients. It was found that the dose requirement needed to suppress the rejection of a retransplanted A kidney was one-fifth that required to suppress the rejection of a primary A kidney in a 0 recipient. The conclusion to be drawn from these results is that indirect antigen processing requires less suppression.
These experiments have some very exciting implications for human kidney graft transplant operations. If one of the major causes of graft rejection of kidneys is the presence of the allogeneic dendritic cell, perfusion of kidneys with antidendritic cell reagents before transplant could be envisaged as an easy, practical way of preventing rejection. Any rejection episodes which would still occur would also presumably be less severe and would not require such aggressive immunotherapy.
Studies on the in vivo localization of human dendritic cells and their interrelationships with T and B lymphocytes were presented by Dr G Janossy (Royal Free Hospital, London), who reviewed some of his immunological data on the different microenvironments which antigenpresenting cells inhabit in various human tissues. To identify these cells two techniques were used: predominantly immunofluorescence with monoclonal antibodies against HLA-DR antigens combined with other differentiation markers on human cells and also histochemical techniques (Table 2) . These two approaches meant that cells could be identified by the presence or absence of et al. 1981 and Poulter et al. 1983 ; in these studies HLA-DR staining and acid phosphatase staining were performed in combination . Thomas et al. 1982a. b • When activated, acid phosphatase macrophages express HLA-DR ... D Y Mason, personal communication various cell surface and intracellular molecules and also by their morphology. Such studies nave the advantage not only of delineating the normal situation but also for allowing interpretation of findings in diseases where abnormalities of immunoregulation are suspected. A general point is that the nomenclature of 'dendritic' cells is confusing. In the original classical studies on rabbit and human tissues this important non-lymphoid cell of the paracortical area has been named 'interdigitating reticular cell'. Later the same cell type has been referred to, in murine studies, as 'dendritic', but this cell of the T-cell region should not be confused with the follicular dendritic cells seen in the germinal centres (a B-cell area).
Using a combination of staining techniques with different enzymes and double labelling with various monoclonal antibodies, it has been possible to establish a picture of which kinds of cells are present and where. Table 2 lists the properties of human interdigitating (dendritic) cells, their close relatives the Langerhans' cells of skin and the so-called 'veiled' cells (which represent the circulating forms of these cells seen in the' lymph). It is clear that these cells are different from the classical macrophages (Table   2 ). Follicular dendritic cells in germinal centres of human spleen can also be visualized by staining tissue sections. Here a specific monoclonal antibody helps identification (made by Dr D Y Mason, personal communication). Antibodies to the C3b receptor also strongly label follicular dendritic cells together 'with a subset of B lymphocytes. Such studies also reveal that the processes of some of the follicular dendritic cells extend into the corona.
After having established the main types of human macrophage-like cells (i.e. interdigitating cells, classical macrophages and follicular dendritic cells), it is interesting to analyse tissues such as the human gut for macrophage HLA-DR and ATPase staining heterogeneity. In the jejunum the dominant population is strongly positive for HLA-DR and contains large amounts of ATPase but virtually no acid phosphatase (interdigitating cells), while only a small proportion contain large amounts of acid phosphatase and virtually no ATPase and HLA-DR (classical macrophage). In the colon the proportion of the two cell types is equal (observations by Drs W Selby and L Poulter).
The thymus is an important microenvironment where T lymphocytes mature and differentiate. Interdigitating (dendritic) cells are assumed to playa vital role during this process and these cells are observed in the thymic medulla. The T lymphocytes found in close association with these interdigitating cells are predominantly of the OKT4 phenotype. The interpretation in terms of T-cell function and maturation remains to be established.
The participation of macrophage and related cell types has been studied in various diseases. As shown in Table 2 , in the normal epidermis the highly HLA-DR, HTA-I(OKT6)-positive, ATPase-positive population corresponds to the Langerhans' cells. The dominant cell type in the lymph nodes of patients SUffering from the rare condition histiocytosis X have been found to correspond to Langerhans' cell types: HLA-DR and HTA-I positive. In mycosis fungoides, the skin is full of T lymphocytes (OKT4 +), which cluster around interdigitating (dendritic) type cells which are HLA-DR positive but HTA-I negative (Thomas et a1. 19820, b) . The observations in rheumatoid arthritis are also interesting. A few cells in normal synovial tissue are positive for HLA-DR. Approximately half these cells are also positive for ATPase and have dendritic cell type morphology. In rheumatoid arthritis the synovium appears completely overrun with these HLA-DR positive cells. Are these activated macrophages or interdigitating cells? Staining with acid phosphatase and ATPase demonstrate that these cells are, in the majority, of interdigitating type.
The data described therefore raise the possibility that some disease states may be associated with cellular imbalances involving' macrophage subsets. This, together with the evidence presented by Professor Batchelor as to the involvement of dendritic cells in graft rejection and that presented by Professor Humphrey demonstrating the importance of the follicular dendritic cell in the development of primary B-cell memory, means that it is vital to carry out further studies on the origins, surface molecular characteristics and mode of antigen presentation by dendritic cells. Only when such information is available will it be possible fully to determine the exact role of these particular cells in the regulation of a normal immune response.
